|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-5-27
|
|
pubmed:abstractText |
To study the pharmacokinetics and pharmacodynamics of the novel topoisomerase I inhibitor and antitumor agent 9-amino-20(S)-camptothecin in patients with solid tumors after repeated oral administration.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
491-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10340914-Administration, Oral,
pubmed-meshheading:10340914-Adult,
pubmed-meshheading:10340914-Aged,
pubmed-meshheading:10340914-Antineoplastic Agents,
pubmed-meshheading:10340914-Camptothecin,
pubmed-meshheading:10340914-Chromatography, High Pressure Liquid,
pubmed-meshheading:10340914-Drug Administration Schedule,
pubmed-meshheading:10340914-Female,
pubmed-meshheading:10340914-Hematologic Diseases,
pubmed-meshheading:10340914-Humans,
pubmed-meshheading:10340914-Male,
pubmed-meshheading:10340914-Middle Aged,
pubmed-meshheading:10340914-Neoplasms,
pubmed-meshheading:10340914-Saliva
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.
|
|
pubmed:affiliation |
Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
